March 2, 2026 — Leads & Copy — Spruce Biosciences, Inc. (Nasdaq: SPRB) announced that Chief Executive Officer Javier Szwarcberg, M.D., M.P.H., will present at two investor conferences in March.
Szwarcberg will attend the Leerink Global Healthcare Conference on March 9, 2026, at 11:20 a.m. ET in Miami, FL. The format will be a fireside chat and 1×1 meetings.
He will also present at The Citizens Life Sciences Conference on March 10, 2026, at 12:30 p.m. ET in Miami, FL. That event will also be a fireside chat and 1×1 meetings.
Live webcasts for each conference can be accessed on the events section of Spruce Biosciences’ website. An archived copy of the webcasts will be available for about 90 days.
Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need.
Source: Spruce Biosciences
